• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Natera Inc (NQ: NTRA )

    105.51 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 105.51
    Bid (Size) 99.21 (1)
    Ask (Size) 107.29 (1)
    Prev. Close 105.51
    Today's Range 105.51 - 105.51
    52wk Range 36.90 - 117.23
    Shares Outstanding 122,802,694
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
    Via Benzinga
    The 3 Best Gene Editing Stocks to Buy in July 2024
    Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
    Via InvestorPlace

    Performance

    YTD
    +70.40%
    +70.40%
    1 Month
    -1.77%
    -1.77%
    3 Month
    +19.07%
    +19.07%
    6 Month
    +58.23%
    +58.23%
    1 Year
    +125.50%
    +125.50%

    More News

    Read More
    $1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
    Via Benzinga
    Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
    From Natera, Inc.
    Via Business Wire
    $100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    $1000 Invested In This Stock 5 Years Ago Would Be Worth $4,400 Today
    Via Benzinga
    Breaking Down Natera: 10 Analysts Share Their Views
    Via Benzinga
    (NTRA) - Analyzing Natera's Short Interest
    Via Benzinga
    Trading SMID Biotech Stocks In A Volatile Market
    Via Talk Markets
    Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
    From Natera, Inc.
    Via Business Wire
    Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
    Via MarketBeat
    Key Takeaways From Natera Analyst Ratings
    Via Benzinga
    Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
    From Natera, Inc.
    Via Business Wire
    Amazon, Natera And A Financial Stock: CNBC's 'Final Trades'
    Via Benzinga
    Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
    From Natera, Inc.
    Via Business Wire
    Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
    Via Benzinga
    Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
    From Natera, Inc.
    Via Business Wire
    Ford Motor, Microsoft And 2 Other Stocks Insiders Are Selling
    Via Benzinga
    Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
    From Natera, Inc.
    Via Business Wire
    Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
    From Natera, Inc.
    Via Business Wire
    NATERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Natera, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.